Vimarsana
Biggest News Aggregation in the World

Page 2 - Dharmil Sheth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dharmil Sheth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dharmil Sheth Today - Breaking & Trending Today

Meet IIM alumnus whose 6-y-o firm bought 25-y-o giant for Rs 4546 crore, he spent Rs 40 crore on luxury Mumbai flat - Vimarsana News

Meet IIM alumnus whose 6-y-o firm bought 25-y-o giant for Rs 4546 crore, he spent Rs 40 crore on luxury Mumbai flat

This entrepreneur's company became the first startup to acquire a majority stake in a listed company, a move that was never seen before in the history of corporate India.

Goldman may Convert Part-debt into Equity in PharmEasy - Vimarsana News

Goldman may Convert Part-debt into Equity in PharmEasy

Goldman Sachs is likely to convert a part of the debt it advanced to PharmEasy into equity, following the upcoming rights issue of about $424 million (₹3,500 crore) by the online pharmacy that is due to open on September 4, sources aware of the matter said.

pharmeasy: Goldman may convert part-debt into equity in PharmEasy - Vimarsana News

pharmeasy: Goldman may convert part-debt into equity in PharmEasy

The online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4

PharmEasy to raise Rs 2,000 cr-Rs 3,000 cr via rights issue: Report - Vimarsana News

PharmEasy to raise Rs 2,000 cr-Rs 3,000 cr via rights issue: Report

Earlier, it was reported that Manipal Group has offered to invest approximately Rs 1,300 crore for an 18 per cent stake in API Holdings.

PharmEasy's $5.5 bn valuation was not wise but acquisitions will bail company out, say experts - Vimarsana News

PharmEasy's $5.5 bn valuation was not wise but acquisitions will bail company out, say experts

PharmEasy has also come under scrutiny for acquiring massive debt. It borrowed $285 million from Goldman Sachs to pay off an earlier debt incurred from Kotak Mahindra Bank to buy Thyrocare